share_log

LSL Pharma Group Inc: REPORT OF EXEMPT DISTRIBUTION EXCLUDING SCHEDULE 1 OF 45-106F1

SEDAR ·  Mar 3, 2023 14:18
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more